Sanofi (SNY) Q3 2026 Earnings Call Transcript
· fool.com · popularity 37/100 · 4 similar stories today
Read the original at fool.com →
Summary
Dupixent sales surge 34.8% as Sanofi upgrades full-year guidance on portfolio momentum. Image source: The Motley Fool. Friday, Oct. 30, 2026 CALL …
Found in: Innovation. Rating basis: 4 other outlets; outlet tier 2 (unlisted); 1 feeds; feed position 14.